Bloomberg Intelligence: TikTok Algorithm to Be Secured (Podcast)

Oracle Corp. is set to secure TikTok's algorithm for a new U.S. version as part of a Trump-backed deal to sell the popular app to American investors. Concurrently, Pfizer agreed to acquire Metsera for approximately $4.9 billion, aiming to bolster its presence in the expanding obesity market. Separately, Oura Health Oy secured $875 million in Series E funding, pushing its valuation to around $10.9 billion.

Analysis

The market is witnessing significant corporate activity across technology and a strategic M&A push in pharmaceuticals. Oracle Corp. is positioned to play a critical role in the US version of TikTok by recreating and securing its algorithm, a move that addresses geopolitical and security concerns under a Trump-backed deal. This places Oracle in a unique and potentially lucrative position beyond a simple equity stake. In the pharmaceutical sector, Pfizer is making a substantial strategic entry into the high-growth obesity market with its agreement to acquire Metsera for an enterprise value of approximately $4.9 billion, signaling a clear intent to compete in this booming therapeutic area. Concurrently, the private markets continue to show robust health, evidenced by Oura Health Oy's $875 million Series E financing round, which brings its valuation to an impressive $10.9 billion. Finally, T-Mobile US Inc. is signaling strategic continuity with its planned leadership transition, promoting COO Srini Gopalan to the CEO position, a move the market appears to view as stable and non-disruptive.

Key Decisions for Investors

• Investors should monitor the final terms of the Oracle-TikTok deal, as Oracle's pivotal role in securing the algorithm could provide a significant, high-margin revenue stream and strengthen its cloud security credentials.
• The $4.9 billion acquisition of Metsera marks a decisive strategic move by Pfizer into the obesity market; it is now critical to re-evaluate Pfizer's long-term growth pipeline against competitors that have a head start in this space.
• T-Mobile's internal CEO promotion suggests stability, but investors should watch for any subtle shifts in capital allocation or competitive strategy under the new leadership beginning November 1st.
• The strong $10.9 billion valuation for Oura Health underscores continued high investor appetite in consumer health-tech, warranting a review of portfolio exposure to this high-growth theme.